Daimei Sasayama, MD, PhD
- 4Articles
- 10.3KReads1
- 2007–2017Active
- 11Collaborators
- 37Citations2
1 Read counts for articles published before 2020 may include some non-human traffic.
2 Citation counts provided by Crossref.
About
Daimei Sasayama, MD, PhD, has published research focused on depression, mood disorders, and schizophrenia/schizoaffective disorders. The work includes clinical case reports and studies on pharmacological interventions such as clozapine readministration, antidepressant augmentation with raloxifene, and the effects of paroxetine combined with other agents. Sasayama’s articles also explore cerebrospinal fluid monoamine metabolite levels in major depressive disorder. The author’s contributions span from 2007 to 2017 in Psychiatrist.com journals.
Publications
Physicians Postgraduate Press, Inc. (PPP) makes no warranties about the accuracy or completeness of any information published in The Journal of Clinical Psychiatry or other PPP materials, and disclaims liability for any use or non-use of that information. Clinicians should not rely solely on these materials and should exercise their own professional judgment when making patient care decisions on an individualized basis.
